Need help finding what you are looking for?
Contact Us
PUBLISHER: IMARC | PRODUCT CODE: 1660669
PUBLISHER: IMARC | PRODUCT CODE: 1660669
Oncology Molecular Diagnostics Market Report by Cancer Type, Product, Technology, End-User, and Region 2025-2033
PUBLISHED:
PAGES: 143 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
The global oncology molecular diagnostics market size reached USD 4.8 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 14.3 Billion by 2033, exhibiting a growth rate (CAGR) of 12.37% during 2025-2033. The rising prevalence of cancer, ongoing advancements in molecular diagnostic technologies, and increased adoption of precision medicine are primarily driving the market's growth.
Oncology molecular diagnostics identify the presence of cancer cells by analyzing their biological molecules. Several tests are performed on the blood, saliva, and tumor tissue samples for detecting and measuring specific genetic sequences in the DNA, RNA, and cell proteins. Oncology molecular diagnostics help perform rapid analysis and provide detailed information that is further utilized in the personalized treatment of cancer. These diagnostics solutions find application in clinical and point-of-care (POC) testing for early detection of cancer. They are also used in blood banks to identify pathogens and infectious diseases present in the donated blood samples.
The rising prevalence of cancer on account of changing lifestyles, growing geriatric population, and the increasing trend of smoking represents one of the major factors impelling the global oncology molecular diagnostics market growth. Apart from this, the escalating demand for rapid and accurate diagnosis, along with advancements in next generation sequencing (NGS) techniques, is contributing to the growth of the market. Furthermore, a rise in the number of individuals suffering from viral and bacterial infections and the increasing participation in blood donation campaigns is positively influencing the demand for oncology molecular diagnostics worldwide. However, due to the sudden outbreak of the coronavirus disease (COVID-19), several healthcare institutions are undertaking steps to mitigate the risk of the pandemic on cancer patients by reducing the number of medical appointments. Moreover, regular screening for cancer patients has witnessed a decline due to the repurposing of diagnostics resources for providing COVID-19 testing and consequent reduction in oncology testing.
Key Market Segmentation:
Breakup by Cancer Type:
- Breast Cancer
- Prostate Cancer
- Colorectal Cancer
- Cervical Cancer
- Liver Cancer
- Lung Cancer
- Blood Cancer
- Others
Breakup by Product:
- Instruments
- Reagents
- Others
Breakup by Technology:
- Polymerase Chain Reaction (PCR)
- In Situ Hybridization
- Chips and Microarrays
- Isothermal Nucleic Acid Amplification Technology (INAAT)
- Mass Spectrometry
- DNA and NGS Sequencing
- Transcription Mediated Amplification (TMA)
- Others
Breakup by End-User:
- Hospitals and Clinics
- Reference Laboratories
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Agilent Technologies, Inc., Abbott Laboratories, Bayer AG, Becton, Dickinson and Company, Danaher Corporation, F. Hoffmann-La Roche AG, Hologic, Inc., Qiagen N.V., Siemens Healthcare and Sysmex Corporation.
Key Questions Answered in This Report
- How has the global oncology molecular diagnostics market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global oncology molecular diagnostics market?
- What are the key regional markets?
- What is the breakup of the market based on the cancer type?
- What is the breakup of the market based on the product?
- What is the breakup of the market based on the technology?
- What is the breakup of the market based on the end-user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global oncology molecular diagnostics market and who are the key players?
- What is the degree of competition in the industry?
Product Code: SR112025A2396
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Oncology Molecular Diagnostics Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Cancer Type
- 6.1 Breast Cancer
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Prostate Cancer
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Colorectal Cancer
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Cervical Cancer
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
- 6.5 Liver Cancer
- 6.5.1 Market Trends
- 6.5.2 Market Forecast
- 6.6 Lung Cancer
- 6.6.1 Market Trends
- 6.6.2 Market Forecast
- 6.7 Blood Cancer
- 6.7.1 Market Trends
- 6.7.2 Market Forecast
- 6.8 Others
- 6.8.1 Market Trends
- 6.8.2 Market Forecast
7 Market Breakup by Product
- 7.1 Instruments
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Reagents
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Others
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
8 Market Breakup by Technology
- 8.1 Polymerase Chain Reaction (PCR)
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 In Situ Hybridization
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Chips and Microarrays
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Isothermal Nucleic Acid Amplification Technology (INAAT)
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
- 8.5 Mass Spectrometry
- 8.5.1 Market Trends
- 8.5.2 Market Forecast
- 8.6 DNA and NGS Sequencing
- 8.6.1 Market Trends
- 8.6.2 Market Forecast
- 8.7 Transcription Mediated Amplification (TMA)
- 8.7.1 Market Trends
- 8.7.2 Market Forecast
- 8.8 Others
- 8.8.1 Market Trends
- 8.8.2 Market Forecast
9 Market Breakup by End-User
- 9.1 Hospitals and Clinics
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Reference Laboratories
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
- 9.3 Others
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
10 Market Breakup by Region
- 10.1 North America
- 10.1.1 United States
- 10.1.1.1 Market Trends
- 10.1.1.2 Market Forecast
- 10.1.2 Canada
- 10.1.2.1 Market Trends
- 10.1.2.2 Market Forecast
- 10.1.1 United States
- 10.2 Asia Pacific
- 10.2.1 China
- 10.2.1.1 Market Trends
- 10.2.1.2 Market Forecast
- 10.2.2 Japan
- 10.2.2.1 Market Trends
- 10.2.2.2 Market Forecast
- 10.2.3 India
- 10.2.3.1 Market Trends
- 10.2.3.2 Market Forecast
- 10.2.4 South Korea
- 10.2.4.1 Market Trends
- 10.2.4.2 Market Forecast
- 10.2.5 Australia
- 10.2.5.1 Market Trends
- 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
- 10.2.6.1 Market Trends
- 10.2.6.2 Market Forecast
- 10.2.7 Others
- 10.2.7.1 Market Trends
- 10.2.7.2 Market Forecast
- 10.2.1 China
- 10.3 Europe
- 10.3.1 Germany
- 10.3.1.1 Market Trends
- 10.3.1.2 Market Forecast
- 10.3.2 France
- 10.3.2.1 Market Trends
- 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
- 10.3.3.1 Market Trends
- 10.3.3.2 Market Forecast
- 10.3.4 Italy
- 10.3.4.1 Market Trends
- 10.3.4.2 Market Forecast
- 10.3.5 Spain
- 10.3.5.1 Market Trends
- 10.3.5.2 Market Forecast
- 10.3.6 Russia
- 10.3.6.1 Market Trends
- 10.3.6.2 Market Forecast
- 10.3.7 Others
- 10.3.7.1 Market Trends
- 10.3.7.2 Market Forecast
- 10.3.1 Germany
- 10.4 Latin America
- 10.4.1 Brazil
- 10.4.1.1 Market Trends
- 10.4.1.2 Market Forecast
- 10.4.2 Mexico
- 10.4.2.1 Market Trends
- 10.4.2.2 Market Forecast
- 10.4.3 Others
- 10.4.3.1 Market Trends
- 10.4.3.2 Market Forecast
- 10.4.1 Brazil
- 10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast
11 SWOT Analysis
- 11.1 Overview
- 11.2 Strengths
- 11.3 Weaknesses
- 11.4 Opportunities
- 11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
- 13.1 Overview
- 13.2 Bargaining Power of Buyers
- 13.3 Bargaining Power of Suppliers
- 13.4 Degree of Competition
- 13.5 Threat of New Entrants
- 13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
- 15.1 Market Structure
- 15.2 Key Players
- 15.3 Profiles of Key Players
- 15.3.1 Agilent Technologies, Inc.
- 15.3.1.1 Company Overview
- 15.3.1.2 Product Portfolio
- 15.3.1.3 Financials
- 15.3.1.4 SWOT Analysis
- 15.3.2 Abbott Laboratories
- 15.3.2.1 Company Overview
- 15.3.2.2 Product Portfolio
- 15.3.2.3 Financials
- 15.3.2.4 SWOT Analysis
- 15.3.3 Bayer AG
- 15.3.3.1 Company Overview
- 15.3.3.2 Product Portfolio
- 15.3.3.3 Financials
- 15.3.3.4 SWOT Analysis
- 15.3.4 Becton, Dickinson and Company
- 15.3.4.1 Company Overview
- 15.3.4.2 Product Portfolio
- 15.3.4.3 Financials
- 15.3.4.4 SWOT Analysis
- 15.3.5 Danaher Corporation
- 15.3.5.1 Company Overview
- 15.3.5.2 Product Portfolio
- 15.3.5.3 SWOT Analysis
- 15.3.6 F. Hoffmann-La Roche AG
- 15.3.6.1 Company Overview
- 15.3.6.2 Product Portfolio
- 15.3.6.3 SWOT Analysis
- 15.3.7 Hologic, Inc.
- 15.3.7.1 Company Overview
- 15.3.7.2 Product Portfolio
- 15.3.7.3 Financials
- 15.3.7.4 SWOT Analysis
- 15.3.8 Qiagen N.V.
- 15.3.8.1 Company Overview
- 15.3.8.2 Product Portfolio
- 15.3.8.3 Financials
- 15.3.8.4 SWOT Analysis
- 15.3.9 Siemens Healthcare
- 15.3.9.1 Company Overview
- 15.3.9.2 Product Portfolio
- 15.3.9.3 Financials
- 15.3.9.4 SWOT Analysis
- 15.3.10 Sysmex Corporation
- 15.3.10.1 Company Overview
- 15.3.10.2 Product Portfolio
- 15.3.10.3 Financials
- 15.3.10.4 SWOT Analysis
- 15.3.1 Agilent Technologies, Inc.
Product Code: SR112025A2396
List of Figures
- Figure 1: Global: Oncology Molecular Diagnostics Market: Major Drivers and Challenges
- Figure 2: Global: Oncology Molecular Diagnostics Market: Sales Value (in Billion USD), 2019-2024
- Figure 3: Global: Oncology Molecular Diagnostics Market: Breakup by Cancer Type (in %), 2024
- Figure 4: Global: Oncology Molecular Diagnostics Market: Breakup by Product (in %), 2024
- Figure 5: Global: Oncology Molecular Diagnostics Market: Breakup by Technology (in %), 2024
- Figure 6: Global: Oncology Molecular Diagnostics Market: Breakup by End-User (in %), 2024
- Figure 7: Global: Oncology Molecular Diagnostics Market: Breakup by Region (in %), 2024
- Figure 8: Global: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Billion USD), 2025-2033
- Figure 9: Global: Oncology Molecular Diagnostics (Breast Cancer) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 10: Global: Oncology Molecular Diagnostics (Breast Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 11: Global: Oncology Molecular Diagnostics (Prostate Cancer) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 12: Global: Oncology Molecular Diagnostics (Prostate Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 13: Global: Oncology Molecular Diagnostics (Colorectal Cancer) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 14: Global: Oncology Molecular Diagnostics (Colorectal Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 15: Global: Oncology Molecular Diagnostics (Cervical Cancer) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 16: Global: Oncology Molecular Diagnostics (Cervical Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 17: Global: Oncology Molecular Diagnostics (Liver Cancer) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 18: Global: Oncology Molecular Diagnostics (Liver Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 19: Global: Oncology Molecular Diagnostics (Lung Cancer) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 20: Global: Oncology Molecular Diagnostics (Lung Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 21: Global: Oncology Molecular Diagnostics (Blood Cancer) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 22: Global: Oncology Molecular Diagnostics (Blood Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 23: Global: Oncology Molecular Diagnostics (Other Cancer Types) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 24: Global: Oncology Molecular Diagnostics (Other Cancer Types) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 25: Global: Oncology Molecular Diagnostics (Instruments) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 26: Global: Oncology Molecular Diagnostics (Instruments) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 27: Global: Oncology Molecular Diagnostics (Reagents) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 28: Global: Oncology Molecular Diagnostics (Reagents) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 29: Global: Oncology Molecular Diagnostics (Other Products) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 30: Global: Oncology Molecular Diagnostics (Other Products) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 31: Global: Oncology Molecular Diagnostics (Polymerase Chain Reaction-PCR) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 32: Global: Oncology Molecular Diagnostics (Polymerase Chain Reaction-PCR) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 33: Global: Oncology Molecular Diagnostics (In Situ Hybridization) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 34: Global: Oncology Molecular Diagnostics (In Situ Hybridization) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 35: Global: Oncology Molecular Diagnostics (Chips and Microarrays) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 36: Global: Oncology Molecular Diagnostics (Chips and Microarrays) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 37: Global: Oncology Molecular Diagnostics (Isothermal Nucleic Acid Amplification Technology-INAAT) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 38: Global: Oncology Molecular Diagnostics (Isothermal Nucleic Acid Amplification Technology-INAAT) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 39: Global: Oncology Molecular Diagnostics (Mass Spectrometry) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 40: Global: Oncology Molecular Diagnostics (Mass Spectrometry) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 41: Global: Oncology Molecular Diagnostics (DNA and NGS Sequencing) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 42: Global: Oncology Molecular Diagnostics (DNA and NGS Sequencing) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 43: Global: Oncology Molecular Diagnostics (Transcription Mediated Amplification-TMA) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 44: Global: Oncology Molecular Diagnostics (Transcription Mediated Amplification-TMA) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 45: Global: Oncology Molecular Diagnostics (Other Technologies) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 46: Global: Oncology Molecular Diagnostics (Other Technologies) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 47: Global: Oncology Molecular Diagnostics (Hospitals and Clinics) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 48: Global: Oncology Molecular Diagnostics (Hospitals and Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 49: Global: Oncology Molecular Diagnostics (Reference Laboratories) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 50: Global: Oncology Molecular Diagnostics (Reference Laboratories) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 51: Global: Oncology Molecular Diagnostics (Other End-Users) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 52: Global: Oncology Molecular Diagnostics (Other End-Users) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 53: North America: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 54: North America: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 55: United States: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 56: United States: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 57: Canada: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 58: Canada: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 59: Asia Pacific: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 60: Asia Pacific: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 61: China: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 62: China: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 63: Japan: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 64: Japan: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 65: India: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 66: India: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 67: South Korea: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 68: South Korea: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 69: Australia: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 70: Australia: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 71: Indonesia: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 72: Indonesia: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 73: Others: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 74: Others: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 75: Europe: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 76: Europe: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 77: Germany: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 78: Germany: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 79: France: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 80: France: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 81: United Kingdom: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 82: United Kingdom: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 83: Italy: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 84: Italy: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 85: Spain: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 86: Spain: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 87: Russia: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 88: Russia: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 89: Others: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 90: Others: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 91: Latin America: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 92: Latin America: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 93: Brazil: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 94: Brazil: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 95: Mexico: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 96: Mexico: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 97: Others: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 98: Others: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 99: Middle East and Africa: Oncology Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
- Figure 100: Middle East and Africa: Oncology Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 101: Global: Oncology Molecular Diagnostics Industry: SWOT Analysis
- Figure 102: Global: Oncology Molecular Diagnostics Industry: Value Chain Analysis
- Figure 103: Global: Oncology Molecular Diagnostics Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Oncology Molecular Diagnostics Market: Key Industry Highlights, 2024 and 2033
- Table 2: Global: Oncology Molecular Diagnostics Market Forecast: Breakup by Cancer Type (in Million USD), 2025-2033
- Table 3: Global: Oncology Molecular Diagnostics Market Forecast: Breakup by Product (in Million USD), 2025-2033
- Table 4: Global: Oncology Molecular Diagnostics Market Forecast: Breakup by Technology (in Million USD), 2025-2033
- Table 5: Global: Oncology Molecular Diagnostics Market Forecast: Breakup by End-User (in Million USD), 2025-2033
- Table 6: Global: Oncology Molecular Diagnostics Market Forecast: Breakup by Region (in Million USD), 2025-2033
- Table 7: Global: Oncology Molecular Diagnostics Market Structure
- Table 8: Global: Oncology Molecular Diagnostics Market: Key Players
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.